Functional phenotyping and genotyping of circulating tumor cells from patients with castration resistant prostate cancer

被引:64
作者
Paris, Pamela L. [1 ]
Kobayashi, Yasuko [1 ]
Zhao, Qiang [2 ]
Zeng, Wei [3 ]
Sridharan, Shivaranjani [1 ]
Fan, Tina [2 ]
Adler, Howard L. [2 ]
Yera, Emmanuel R. [1 ]
Zarrabi, M. H. [4 ]
Zucker, Stanley [4 ]
Simko, Jeffry [1 ]
Chen, Wen-Tien [2 ,3 ]
Rosenberg, Jonathan [5 ]
机构
[1] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA
[2] SUNY Stony Brook, Ctr Canc, Stony Brook, NY 11794 USA
[3] Vitatex Inc, Stony Brook, NY 11790 USA
[4] Vet Adm Med Ctr, Northport, NY 11768 USA
[5] Univ Calif San Francisco, Div Hematol & Oncol, San Francisco, CA 94115 USA
关键词
Prostate cancer; Metastasis; Circulating tumor cells; Blood micrometastases; DNA COPY NUMBER; COMPARATIVE GENOMIC HYBRIDIZATION; HIGH-RESOLUTION ANALYSIS; BREAST-CANCER; PERIPHERAL-BLOOD; OLIGONUCLEOTIDE CGH; ADHESION MOLECULE; BONE-MARROW; METASTASIS; ARRAY;
D O I
10.1016/j.canlet.2008.12.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Circulating tumor cells (CTCs) hold promise for studying advanced prostate cancer. A functional collagen adhesion matrix (CAM) assay was used to enrich CTCs from prostate cancer patients' blood. CAM ingestion and epithelial immuno-staining identified CTCs, which were genotyped using oligonucleotide array comparative genomic hybridization. The highest CTC counts were observed in men with metastatic castration resistant prostate cancer (CRPC) compared to castration sensitive prostate cancer. Copy number profiles for CRPC CTCs were similar to paired solid tumor DNA, and distinct from corresponding DNA from the residual CAM-depleted blood. CAM CTC enrichment may allow cellular and genetic analyses in prostate cancer. (c) 2008 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:164 / 173
页数:10
相关论文
共 50 条
[31]   Circulating Tumor Cells in Biochemical Recurrence of Prostate Cancer [J].
Aragon-Ching, Jeanny B. ;
Siegel, Robert S. ;
Frazier, Harold, II ;
Andrawis, Ramez ;
Hendricks, Frederick ;
Phillips, Michael ;
Jarrett, Thomas ;
Guebre-Xabiher, Hiwot ;
Patierno, Steven ;
Simmens, Samuel J. .
CLINICAL GENITOURINARY CANCER, 2015, 13 (05) :E341-E345
[32]   Circulating tumor cells and survival in abiraterone- and enzalutamide-treated patients with castration-resistant prostate cancer [J].
De Laere, Bram ;
Oeyen, Steffi ;
Van Oyen, Peter ;
Ghysel, Christophe ;
Ampe, Jozef ;
Ost, Piet ;
Demey, Wim ;
Hoekx, Lucien ;
Schrijvers, Dirk ;
Brouwers, Barbara ;
Lybaert, Willem ;
Everaert, Els ;
Van Kerckhove, Piet ;
De Maeseneer, Daan ;
Strijbos, Michiel ;
Bols, Alain ;
Fransis, Karen ;
Beije, Nick ;
de Kruijff, Inge ;
van Dam, Valerie ;
Brouwer, Anja ;
van Dam, Pieter-Jan ;
Van den Eynden, Gert ;
Rutten, Annemie ;
Sleijfer, Stefan ;
Vandebroek, Jean ;
Van Laere, Steven ;
Dirix, Luc .
PROSTATE, 2018, 78 (06) :435-445
[33]   Synaptophysin expression on circulating tumor cells in patients with castration resistant prostate cancer undergoing treatment with abiraterone acetate or enzalutamide [J].
Pal, Sumanta K. ;
He, Miaoling ;
Chen, Lin ;
Yang, Lixin ;
Pillai, Raju ;
Twardowski, Przemyslaw ;
Hsu, JoAnn ;
Kortylewski, Marcin ;
Jones, Jeremy O. .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (04) :162.e1-162.e6
[34]   AR splice variants in circulating tumor cells of patients with castration-resistant prostate cancer: relation with outcome to cabazitaxel [J].
Sieuwerts, Anieta M. ;
Onstenk, Wendy ;
Kraan, Jaco ;
Beaufort, Corine M. ;
Van, Mai ;
De Laere, Bram ;
Dirix, Luc Y. ;
Hamberg, Paul ;
Beeker, Aart ;
Meulenbeld, Hielke J. ;
Creemers, Geert-Jan ;
van Weerden, Wytske M. ;
Jenster, Guido W. ;
Nieuweboer, Annemieke J. M. ;
Mathijssen, Ron H. J. ;
de Wit, Ronald ;
Martens, John W. M. ;
Sleijfer, Stefan .
MOLECULAR ONCOLOGY, 2019, 13 (08) :1795-1807
[35]   TOPK is highly expressed in circulating tumor cells, enabling metastasis of prostate cancer [J].
Sun, Huimin ;
Zhang, Lei ;
Shi, Changhong ;
Hu, Peizhen ;
Yan, Wei ;
Wang, Zhe ;
Duan, Qiuhong ;
Lu, Fan ;
Qin, Lipeng ;
Lu, Tao ;
Xiao, Juanjuan ;
Wang, Yingmei ;
Zhu, Feng ;
Shao, Chen .
ONCOTARGET, 2015, 6 (14) :12392-12404
[36]   Analysis of Circulating Tumor Cells in Prostate Cancer Patients at PSA Recurrence and Review of the Literature [J].
Grisanti, Salvatore ;
Antonelli, Alessandro ;
Buglione, Michela ;
Almici, Camillo ;
Foroni, Chiara ;
Sodano, Mario ;
Triggiani, Luca ;
Greco, Diana ;
Palumbo, Carlotta ;
Marini, Mirella ;
Magrini, Stefano M. ;
Berruti, Alfredo ;
Simeone, Claudio .
ANTICANCER RESEARCH, 2016, 36 (06) :2975-2981
[37]   Detection of circulating tumor cells in patients with prostate cancer [J].
Repiská, V ;
Miklosi, M ;
Zummerová, A ;
Danisovic, L ;
Hoffmann, J ;
Breza, J ;
Vojtassák, J .
BIOLOGIA, 2005, 60 (06) :703-709
[38]   Clinical significance of circulating tumor cells in breast cancer patients [J].
Tao, Min ;
Ma, Deliang ;
Li, Yan ;
Zhou, Chong ;
Zhang, Yinsheng ;
Duan, Weiming ;
Xu, Xiujuan ;
Wang, Rong ;
Wu, Lingzhi ;
Liu, Haiyan .
BREAST CANCER RESEARCH AND TREATMENT, 2011, 129 (01) :247-254
[39]   Morphological Differences between Circulating Tumor Cells from Prostate Cancer Patients and Cultured Prostate Cancer Cells [J].
Park, Sunyoung ;
Ang, Richard R. ;
Duffy, Simon P. ;
Bazov, Jenny ;
Chi, Kim N. ;
Black, Peter C. ;
Ma, Hongshen .
PLOS ONE, 2014, 9 (01)
[40]   Targeting Cancer Stem Cells in Castration-Resistant Prostate Cancer [J].
Yun, Eun-Jin ;
Zhou, Jiancheng ;
Lin, Chun-Jung ;
Hernandez, Elizabeth ;
Fazli, Ladan ;
Gleave, Martin ;
Hsieh, Jer-Tsong .
CLINICAL CANCER RESEARCH, 2016, 22 (03) :670-679